Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
27.94
-0.62 (-2.17%)
At close: Apr 28, 2026, 4:00 PM EDT
28.20
+0.26 (0.93%)
After-hours: Apr 28, 2026, 7:23 PM EDT
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $2.06 billion as of April 28, 2026. Its market cap has increased by 178.61% in one year.
Market Cap
2.06B
Enterprise Value
1.81B
1-Year Change
178.61%
Ranking
Category
Stock Price
$27.94
Market Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $2.06B, an increase of 525.55%. That is a compound annual growth rate of 22.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 2.06B | 4.58% |
| Dec 31, 2025 | 1.97B | 95.40% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sarepta Therapeutics | 2.23B |
| Ascentage Pharma Group International | 2.16B |
| Tyra Biosciences | 2.15B |
| Mineralys Therapeutics | 2.14B |
| Adaptive Biotechnologies | 2.14B |
| Aurinia Pharmaceuticals | 2.12B |
| Definium Therapeutics | 2.11B |
| Ocular Therapeutix | 2.04B |